Evidence map›Paper›PMID 30850961›Full record

ReviewDermatology and therapy2019

Understanding the Burden of Atopic Dermatitis in Africa and the Middle East.

Khalid Abdullah Mohammad Al-Afif, Mohamad Ali Buraik, Joerg Buddenkotte, Mohamed Mounir, Robert Gerber, Haytham Mohamed Ahmed, Anna M Tallman, Martin Steinhoff

Abstract readReview
In one paragraph

Review in Dermatology and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Khalid Abdullah Mohammad Al-AfifAl Noor Specialist Hospital, Mecca, Saudi Arabia. kh_alafif5@yahoo.com.
Mohamad Ali BuraikDepartment of Dermatology, King Fahd Central Hospital, Jizan, Saudi Arabia.
Joerg BuddenkotteDepartment of Dermatology and HMC Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
Mohamed MounirDepartments of Inflammation and Immunology and Emerging Markets, Pfizer Inc, Dubai, United Arab Emirates.
Robert GerberDepartments of Outcomes and Evidence and Statistics, Pfizer Inc, Groton, CT, USA.
Haytham Mohamed AhmedDepartments of Inflammation and Immunology and Emerging Markets, Pfizer Inc, Jeddah, Saudi Arabia.
Anna M TallmanGlobal Medical Affairs, Pfizer Inc, New York, NY, USA.
Martin SteinhoffDepartment of Dermatology and HMC Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intensely pruritic lesions. The prevalence of atopic dermatitis is increasing in developing regions, including Africa and the Middle East. However, these regions are underrepresented in the dermatology literature, and a better understanding of the growing burden of atopic dermatitis in Africa and the Middle East is necessary. Herein, we summarize current knowledge on atopic dermatitis epidemiology, disease burden, and treatment options in Africa and the Middle East, highlighting the unmet needs of patients in these regions. With these needs in mind, we provide clinical recommendations for appropriate management of atopic dermatitis in Africa and the Middle East.

fundingPfizer Inc. Plain language summary available for this article.

Indexed as

AfricaAtopic dermatitisMiddle EastPrevalenceQuality of lifeTherapeutics

Identifiers

PMID30850961
PMCPMC6522619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.